Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines

British Journal of Cancer

Volumn 79, Issue 7-8, 1999, Pages 1005-1011

  Hougaard, S ^a   Norgaard P ^a   Abrahamsen, N ^a   Moses, H L ^c   Spang Thomsen, M ^b   Poulsen, H Skovgaard ^a  

^a FINSEN LABORATORY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Cell lines; Mutation; Small cell lung cancer; Transcription; Transforming growth factor ; Type II receptor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BENZO[A]PYRENE; MESSENGER RNA; POLYADENYLIC ACID; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CHROMOSOME 3P; DNA METHYLATION; GENE MUTATION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; NORTHERN BLOTTING; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; SOUTHERN BLOTTING; STOP CODON;

BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CARCINOMA, SMALL CELL; HUMANS; LUNG NEOPLASMS; METHYLATION; MUTAGENESIS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0010238313     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690161     Document Type: Article

References (41)

1. Berendsen HH, De Leij L, De Vries EGE, Mesander G, Mulder NH, De Jong B, Buys CHCM, Postmus PE, Poppema S, Sluiter HJ and The HT (1988) Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res 48: 6891-6899
2. Carney DN, Gazdar AF, Bepler G, Guccion JG, MarangoS PJ, Moody TW, Zweig MH and Minna JD (1985) Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45: 2913-2923
3. null mice is prognostic for a high risk of malignant conversion. Cancer Res 54: 5831-5836
4. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A and Akhurst RJ (1996) TGF-β1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531-542
5. Damstrup L, Rygaard K, Spang-Thomsen M and Poulsen HS (1993) Expression of the transforming growth factor β (TGFβ) receptors and TGF-β1. TGF-β2 and TGF-β3 in human small cell lung cancer cell lines. Br J Cancer 67: 1015-1021
6. de Jonge RR, Garrigue-Antar L, Velluci VF and Reiss M (1997) Frequent inactivation of the transforming growth factor β type II receptor in small-cell lung carcinoma cells. Oncology Res 9: 89-98
7. De Leil L, Postmus PE, Buys CHCM, Elema JD, Ramaekers F, Poppema S, Brouwer M, Van Der Veen AY, Mesander G and The TH (1985) Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res 45: 6024-6033
8. Denissenko MF, Pao A, Tang M-S and Pfeifer GP (1996) Preferential formation of benzoe[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274: 430-432
9. Engelholm SA, Spang-Thomsen M, Vindeløv LL, Brünner N, Nielsen MH, Hirsch F and Hansen HH (1986) Comparison of characteristics of human small cell carcinoma of the lung in patients, in vitro and transplanted into nude mice. Acta Pathol Microbiol Scand Sect A Pathol 94: 325-336
10. Ferguson AT, Lapidus RG, Baylin SB and Davidson NE (1995) Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can activate estrogen receptor expression. Cancer Res 55: 2279-2283
11. Garrague-Antar L, Muñoz-Antonia T, Antonia SJ, Gesmonde J, Velluci VF and Reiss M (1995) Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res 55: 3982-3987
12. Geiser AG, Burmester JK, Webbink R, Roberts AB and Sporn MB (1992) Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. J Biol Chem 267: 2588-2593
13. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, van Tornout JM and Jones PJ (1995) Methylation of 5′CpG island of p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531-4535
14. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarnard PF, Isaacs WB, Pith PM, Davidson PM, Davidson NE and Baylin SB (1995) E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195-5199
15. Inagaki M, Moustakas A, Lin HY, Lodish HF and Carr BI (1993) Growth inhibition by transforming growth factor β (TGF-β) type 1 is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc Natl Acad Sci USA 90: 5359-5363
16. Kingsley DM (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133-146
17. Liabakk N, Talbot I, Smith RA, Wilkinson K and Balkwill F (1996) Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancers. Cancer Res 56: 190-196
18. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA and Lodish HF (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775-785
19. Lu S-L, Akiyami Y, Nagasaki H, Saiton K and Yuasa Y (1995) Mutations of the transforming growth faetor-beta type II receptor gene and genomic instability in hereditary nonpolyposis colorectal cancer. Biochem Biophys Res Commun 216: 452-457
20. Lu S-L, Zhang W-C, Akiyami Y, Nomizu T and Yuasa Y (1996) Genomic structure of the transforming growth factor β type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res 56: 4595-4598
21. Makos M, Nelkin BD, Lerman MI, Latif F, Zbar B and Baylin SB (1995) Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci USA 89: 1929-1933
22. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M and Willson JKV (1995) Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338
23. Mathew S, Murty VVVS, Cheifetz S, George D, Massagué J and Chaganti RSK (1994) Transforming growth factor receptor gene TGFβR2 maps to human chromosome band 3p22. Genomics 20: 114-115
24. Mitsudomi T, Ogana T, Nishida A, Usaki T, Sugio K, Yasumo K, Sugimachi K and Gazdar AF (1996) Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implications. Clin Cancer Res 2: 1185-1188
25. Moses HL. (1992) TGFβ regulation of epithelial cell proliferation. Mol Reprod Dev 32: 179-184
26. Myeroff L, Parsons R, Kim S-J, Hedrik L, Rho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, Bang Y-J, Lee HY, Park J-G, Lynch HT, Roberts AB, Vogelstein B and Markowitz SD (1995) Transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55: 5545-5547
27. Nørgaard P, Damstrup L, Rygaard K, Spang-Thomsen M and Poulsen HS (1994) Growth suppression by transforming growth factor-β1 of human small cell lung cancer cell lines is associated to expression of the type II receptor. Br J Cancer 69: 802-808
28. Nørgaard P, Hougaard S. Spang-Thomsen M and Poulsen HS (1995) Transforming growth factor β and cancer. Cancer Treat Rev 21: 367-403
29. Nørgaard P, Spang-Thomsen M and Poulsen HS (1996) Expression and autoregulation of transforming growth factor β receptor mRNA in small-cell lung cancer cell lines. Br J Cancer 73: 1037-1043
30. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB and Sporn MB (1994) Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91: 8772-8776
31. Peltengill OS, Sorenson GD, Wurster-Hill D, Curphey TJ, Noll WW, Cate CC and Maurer LH (1980) Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer (Phila.) 45: 906-918
32. Pierce DF, Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ Jr and Moses HL (1995) Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc Natl Acad Sci USA 92: 4254-4258
33. Roberts AB and Sporn MB (1990) The Transforming Growth Factor-βs. Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors, Sporn MB and Roberts AB (eds), pp. 419-472. Springer Verlag: Heidelberg
34. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY
35. Sun L, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang X-F and Brattain MG (1994) Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455
36. Takenoshita S, Hagiwara K, Gemma A, Nagashima M, Ryberg D, Lindsledt BA, Bennett WP, Haugen A and Harris CC (1997) Absence of mutations in the transforming growth factor-beta type II receptor in sporadic lung cancers with microsatellite instability and rare H-rasl alleles. Carcinogenesis 18: 1427-1429
37. Tani M, Takenoshita S, Kohno T, Hagiwara K, Nagamachi Y, Harris CC and Yokota JRA (1997) Infrequent mutations of the transforming growth factor beta type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions. Carcinogenesis 18: 1119-1121
38. Todd S, Franklin WA, Varella-Garcia M, Kennedy T, Hillikwer CE, Hahner JrL, Anderson M, Wiest JS, Drabkin HA and Gemmill RM (1997) Homozygous deletions of human chromosome 3p in lung tumors. Cancer Res 57: 1344-1352
39. Vincent F, Nagashima M, Takenoshita S, Khan MA, Gemma A, Hagiwara K and Bennett WP (1997) Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Oncogene 15: 117-122
40. Wang J, Sun L, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JK and Brattain MG (1995) Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044-22049
41. Wrana JL, Attisano L, Wieser F, Ventura F and Massagué J (1994) Mechanism of activation of the TGF-β receptor. Nature 370: 341-347